The Experts below are selected from a list of 14670 Experts worldwide ranked by ideXlab platform

Henry Buchwald - One of the best experts on this subject based on the ideXlab platform.

  • consensus conference statement bariatric surgery for Morbid Obesity health implications for patients health professionals and third party payers
    Surgery for Obesity and Related Diseases, 2005
    Co-Authors: Henry Buchwald
    Abstract:

    c This Consensus Statement on the state of bariatric surery for Morbid Obesity has been prepared by a panel of roadly based and experienced experts based on presentaions by investigators working in areas relevant to current uestions in this field during a 11⁄2-day public session; quesions and statements from conference attendees during open iscussion periods that were part of the public sessions; and losed deliberations by the panel. This statement is an inependent report of the panel and is not a policy statement f the American Society for Bariatric Surgery or any of the ponsors or endorsers of the Consensus Conference. hough the Consensus Conference is modeled on the format sed by the National Institutes of Health (NIH), the planing, execution, and development of the conference and reparation of this statement were carried out without any elationship with the NIH. In addition, although the Conerence was addressed by the Honorable Tommy Thompon, Secretary of Health and Human Services, this report is ot a policy statement of the federal government. This statement reflects the panel’s assessment of medical nowledge available at the time it was written. Knowledge bout bariatric surgery and Morbid Obesity is dynamic, and

  • bariatric surgery for Morbid Obesity health implications for patients health professionals and third party payers
    Journal of The American College of Surgeons, 2005
    Co-Authors: Henry Buchwald
    Abstract:

    c his Consensus Statement on the state of bariatric surery for Morbid Obesity has been prepared by a panel of roadly based and experienced experts based on presenations by investigators working in areas relevant to curent questions in this field during a 11⁄2-day public sesion; questions and statements from conference ttendees during open discussion periods that were part f the public sessions; and closed deliberations by the anel. This statement is an independent report of the anel and is not a policy statement of the American ociety for Bariatric Surgery or any of the sponsors or ndorsers of the Consensus Conference. Though the onsensus Conference is modeled on the format used by he National Institutes of Health (NIH), the planning, xecution, and development of the conference and prepration of this statement were carried out without any elationship with the NIH. In addition, although the onference was addressed by the Honorable Tommy hompson, Secretary of Health and Human Services, his report is not a policy statement of the federal overnment. This statement reflects the panel’s assessment of medcal knowledge available at the time it was written. nowledge about bariatric surgery and Morbid Obesity is

Michel Gagner - One of the best experts on this subject based on the ideXlab platform.

  • laparoscopic sleeve gastrectomy for Morbid Obesity
    American Journal of Surgery, 2008
    Co-Authors: Alfons Pomp, Gregory Dakin, Manish Parikh, Michel Gagner
    Abstract:

    Abstract The epidemic of Obesity in the United States is a major public health issue and more than a third of adults are now considered obese (body mass index ≥ 30 kg/m 2 ). Surgery for Morbid Obesity, bariatric surgery, is the most durable treatment for this disease and about 140,000 cases are performed annually. Laparoscopic sleeve gastrectomy (LSG) has been advocated as the first of a 2-stage procedure for the high-risk, super-obese patient. More recently, LSG has been studied as a single-stage procedure for weight loss in the Morbidly obese. LSG has been shown in initial studies to produce excellent excess weight loss comparable with laparoscopic Roux-en-Y gastric bypass in many series with a very low incidence of major complications and death. We describe our technique for LSG.

  • sleeve gastrectomy for Morbid Obesity
    Obesity Surgery, 2007
    Co-Authors: Andrew A Gumbs, Michel Gagner, Gregory Dakin, Alfons Pomp
    Abstract:

    The rising prevalence of Morbid Obesity and the increased incidence of super-obese patients (BMI >50 kg/m2) seeking surgical treatments has led to the search for surgical techniques that provide adequate EWL with the least possible Morbidity. Sleeve gastrectomy (SG) was initially added as a modification to the biliopancreatic diversion (BPD) and then combined with a duodenal switch (DS) in 1988. It was first performed laparoscopically in 1999 as part of a DS and subsequently done alone as a staged procedure in 2000. With the revelation that patients experienced weight loss after SG, interest in using this procedure as a bridge to more definitive surgical treatment has risen. Benefits of SG include the low rate of complications, the avoidance of foreign material, the maintenance of normal gastro-intestinal continuity, the absence of malabsorption and the ability to convert to multiple other operations. Reduction of the ghrelinproducing stomach mass may account for its superiority to other gastric restrictive procedures. SG should be in the armamentarium of all bariatric surgeons. Nonetheless, long-term studies are necessary to see if it is a durable procedure in the treatment of Morbid Obesity.

  • laparoscopic duodenal switch for Morbid Obesity
    Expert Review of Medical Devices, 2006
    Co-Authors: Michel Gagner, Camilo Boza
    Abstract:

    Laparoscopic duodenal switch gives a consistent excess weight loss of 70–80% with acceptable long-term nutritional complications. It is especially indicated for super-obese patients with a body mass index greater than 50 kg/m2. A systematic review of the literature and results of open and laparoscopic duodenal switch is thoroughly presented. Also presented for the authors’ surgical colleagues are some technical details concerning their preferred method. Meta-analysis now demonstrate a low mortality rate for the laparoscopic procedure close to 0.5%, and operative times close to 200 min. Laparoscopic duodenal switch is likely to increase in popularly for the treatment of Morbid Obesity, especially with the recent advent of laparoscopic sleeve gastrectomy for higher-risk patients.

Luis Grande - One of the best experts on this subject based on the ideXlab platform.

James Toouli - One of the best experts on this subject based on the ideXlab platform.

Jungchien Chen - One of the best experts on this subject based on the ideXlab platform.